2017
DOI: 10.1016/j.ejmech.2017.06.036
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
14
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 22 publications
2
14
0
Order By: Relevance
“…However, chronic exposure to donepezil has been reported to induce severe dose‐dependent adverse effects on zebrafish behavior (Audira et al, 2020). In our study, the decrease in AChE activity by DLX is in agreement with previous studies in which antidepressants, such as citalopram, fluoxetine, paroxetine, sertraline, and several structural derivatives of escitalopram, reduce cholinesterase expression (Müller et al, 2002; Munawar et al, 2015; Nisa et al, 2017; Rockwood et al, 2011). In particular, DLX‐treated rats show a decline in cholinesterase and improved cognition (Shaik et al, 2019).…”
Section: Discussionsupporting
confidence: 93%
“…However, chronic exposure to donepezil has been reported to induce severe dose‐dependent adverse effects on zebrafish behavior (Audira et al, 2020). In our study, the decrease in AChE activity by DLX is in agreement with previous studies in which antidepressants, such as citalopram, fluoxetine, paroxetine, sertraline, and several structural derivatives of escitalopram, reduce cholinesterase expression (Müller et al, 2002; Munawar et al, 2015; Nisa et al, 2017; Rockwood et al, 2011). In particular, DLX‐treated rats show a decline in cholinesterase and improved cognition (Shaik et al, 2019).…”
Section: Discussionsupporting
confidence: 93%
“…In earlier studies, antidepressants such as citalopram, fluoxetine, paroxetine, sertraline, and several structural derivatives of escitalopram significantly inhibited cholinesterases. [34][35][36][37] Consistent with earlier studies, rivastigmine and escitalopram caused further decline in AChE enzyme levels, thereby protecting and sustaining the function of remaining ACh from cholinergic nerve endings and improving cognition which was evident from the results of MWM trials in the present study. Furthermore, duloxetine-treated rats showed a decline in cholinesterase and improved cognition.…”
Section: Discussionsupporting
confidence: 91%
“…Purity and homogeneity of known compounds were confirmed by measuring their m.p. for 1a [44], 1c [46], 1e [47], 1f [48], 1g [49], 1h-j [50], 2d [49], 2g [51], 4b [89], 4c [90], 6a [60], 6d [91], 6e [57], 6f [92], 7a [93], 7b [56], 7d [61], 7f [62], 8b [94], and 8c [95], or boiling points for 6b [96], 7e [97], FT-IR spectra for 1a [51], 1g [52], 1h-i [50], 2g [51], 1 H-and 13 C-NMR spectra for 1c [46], 1e [47], 1f [48], 1g [46], 1h-j [50], 2c [48], 2d [53] and/or HRMS for 2c [48], and comparing them with literature data. All new hydrazide-hydrazones 1b, 1d, 2a-b, 2e-f, 2h, 3a-g, were fully characterized.…”
Section: Reagents and Materialsmentioning
confidence: 99%